FDA Moves to Revolutionize Drug Development With Real-Time Clinical Trial Data
FDA launches real-time clinical trial initiative with $AMGN and $AZN pilots, aiming to accelerate drug approvals and eliminate traditional reporting delays.
AMGNAZNclinical datadrug development